Vice President, US Strategic Accounts
![]() | |
![]() United States, Massachusetts, Cambridge | |
![]() 675 West Kendall Street (Show on map) | |
![]() | |
This role is considered Virtual.
Vice President, US Strategic Accounts We are seeking a proven leader with the strategic vision, executive presence, and collaborative style to shape our US Strategic Accounts strategy and go-to-market approach. Passionate about developing people and advancing patient care, this individual will play a critical role in driving enterprise growth and impact. Reporting to the SVP, Head of US TTR, the Vice President, the VP of US Strategic Accounts will define and execute Alnylam's account strategy across organized customers including health systems, Integrated Delivery Networks (IDNs), and Integrated Provider Networks (IPNs) and other organized provider networks. Leading a national team of Strategic Account Leads, this executive will build trusted partnerships with key stakeholders and deliver results that support both near- and long-term business objectives. The ideal candidate brings extensive expertise in organized customer environments, a strong track record of launching and scaling commercial strategies, deep relationships with organized customer leaders, and a commitment to leading teams that expand patient identification and access and deliver lasting value. Key Responsibilities
Qualifications
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. > |